| Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer US Kosgodage, AV Nunn, GW Guy, EL Thomas, JM Inal, S Lange Frontiers in pharmacology 9, 319517, 2018 | 124 | 2018 |
| Chloramidine/bisindolylmaleimide-I-mediated inhibition of exosome and microvesicle release and enhanced efficacy of cancer chemotherapy US Kosgodage, RP Trindade, PR Thompson, JM Inal, S Lange International journal of molecular sciences 18 (5), 1007, 2017 | 124 | 2017 |
| Blood/plasma secretome and microvesicles JM Inal, U Kosgodage, S Azam, D Stratton, S Antwi-Baffour, S Lange Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1834 (11), 2317-2325, 2013 | 116 | 2013 |
| Cannabidiol is a novel modulator of bacterial membrane vesicles US Kosgodage, P Matewele, B Awamaria, I Kraev, P Warde, ... Frontiers in cellular and infection microbiology 9, 324, 2019 | 73 | 2019 |
| The emerging role of exosome and microvesicle‐(EMV‐) based cancer therapeutics and immunotherapy C Moore, U Kosgodage, S Lange, JM Inal International journal of cancer 141 (3), 428-436, 2017 | 73 | 2017 |
| Peptidylarginine deiminases—roles in cancer and neurodegeneration and possible avenues for therapeutic intervention via modulation of exosome and microvesicle (EMV) release? S Lange, M Gallagher, S Kholia, US Kosgodage, M Hristova, J Hardy, ... International journal of molecular sciences 18 (6), 1196, 2017 | 62 | 2017 |
| Peptidylarginine deiminase inhibitors reduce bacterial membrane vesicle release and sensitize bacteria to antibiotic treatment US Kosgodage, P Matewele, G Mastroianni, I Kraev, D Brotherton, ... Frontiers in cellular and infection microbiology 9, 227, 2019 | 57 | 2019 |
| Peptidylarginine deiminases post-translationally deiminate prohibitin and modulate extracellular vesicle release and microRNAs in glioblastoma multiforme US Kosgodage, P Uysal-Onganer, A MacLatchy, I Kraev, NP Chatterton, ... International journal of molecular sciences 20 (1), 103, 2018 | 55 | 2018 |
| Cannabidiol affects extracellular vesicle release, miR21 and miR126, and reduces prohibitin protein in glioblastoma multiforme cells US Kosgodage, P Uysal-Onganer, A MacLatchy, R Mould, AV Nunn, ... Translational oncology 12 (3), 513-522, 2019 | 51 | 2019 |
| Treatment of prostate cancer using deimination antagonists and microvesicle technology S Lange, S Kholia, US Kosgodage, JM Inal Protein Deimination in Human Health and Disease, 413-425, 2017 | 4 | 2017 |
| Inhibition of extracellular vesicle release enhances cancer chemotherapy and inhibition of outer membrane vesicle release sensitises bacteria to antibiotic and bacteriophage … US Kosgodage London Metropolitan University, 2019 | 1 | 2019 |
| Let us know how access to this document benefits you. US Kosgodage | | 2017 |
| Peptidylarginine Deiminases as Mediators of Microvesicular Release-Novel Therapeutic Interventions S Lange, S Kholia, U Kosgodage, M Hristova, J Hardy, JM Inal Preprints, 2017 | | 2017 |
| Inhibitors of microvesicle release with the potential to enhance effectivity of cancer chemotherapy J Inal, US Kosgodage, S Lange The Fifth International Meeting of ISEV, ISEV2016, Rotterdam, The …, 2016 | | 2016 |
| PW1. 04. Inhibitors of microvesicle release with the potential to enhance effectivity of cancer chemotherapy S Lange, U Kosgodage, JM Inal Journal of Extracellular Vesicles 5, 34, 2016 | | 2016 |
| PF7. 09 Non-phagocytic epithelial cells take up microvesicles by micropinocytosis S Lange, U Kosgodage, JM Inal Journal of Extracellular Vesicles 5, 172, 2016 | | 2016 |
Jameel InalProfessor of Immunobiology, London Metropolitan UniversityVerified email at londonmet.ac.uk
